homovanillic acid has been researched along with oxazolidin-2-one in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berlin, I; Hergueta, T; Payan, C; Puech, AJ; Robin, L; Thiede, HM; Zimmer, R | 1 |
Garrick, NA; Linnoila, M; Murphy, DL; Seppala, T | 1 |
Fuller, RW; Hemrick-Luecke, SK | 1 |
Waldmeier, PC | 1 |
1 trial(s) available for homovanillic acid and oxazolidin-2-one
Article | Year |
---|---|
Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.
Topics: Adult; Benzamides; Double-Blind Method; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Psychometrics; Psychophysiology | 1990 |
3 other study(ies) available for homovanillic acid and oxazolidin-2-one
Article | Year |
---|---|
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone.
Topics: Animals; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones | 1985 |
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines | 1985 |
On the reversibility of reversible MAO inhibitors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Brain; Clorgyline; Dopamine; Female; Homovanillic Acid; Kinetics; Liver; Moclobemide; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Phenethylamines; Piperidines; Rats; Rats, Inbred Strains; Serotonin | 1985 |